nodes	percent_of_prediction	percent_of_DWPC	metapath
Ticagrelor—ABCB1—peripheral nervous system neoplasm	0.48	1	CbGaD
Ticagrelor—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0596	0.167	CbGbCtD
Ticagrelor—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0596	0.167	CbGbCtD
Ticagrelor—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0413	0.116	CbGbCtD
Ticagrelor—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0357	0.1	CbGbCtD
Ticagrelor—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0332	0.0931	CbGbCtD
Ticagrelor—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0254	0.0714	CbGbCtD
Ticagrelor—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0237	0.0665	CbGbCtD
Ticagrelor—ABCB1—Etoposide—peripheral nervous system neoplasm	0.0233	0.0654	CbGbCtD
Ticagrelor—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.0159	0.0446	CbGbCtD
Ticagrelor—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.0152	0.0428	CbGbCtD
Ticagrelor—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.014	0.0392	CbGbCtD
Ticagrelor—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00952	0.0267	CbGbCtD
Ticagrelor—Immune system disorder—Etoposide—peripheral nervous system neoplasm	0.000241	0.00147	CcSEcCtD
Ticagrelor—Mediastinal disorder—Etoposide—peripheral nervous system neoplasm	0.00024	0.00147	CcSEcCtD
Ticagrelor—Shock—Alitretinoin—peripheral nervous system neoplasm	0.000239	0.00146	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Epirubicin—peripheral nervous system neoplasm	0.000238	0.00145	CcSEcCtD
Ticagrelor—Nervous system disorder—Alitretinoin—peripheral nervous system neoplasm	0.000238	0.00145	CcSEcCtD
Ticagrelor—Hypersensitivity—Topotecan—peripheral nervous system neoplasm	0.000238	0.00145	CcSEcCtD
Ticagrelor—Hypersensitivity—Tretinoin—peripheral nervous system neoplasm	0.000236	0.00144	CcSEcCtD
Ticagrelor—Hypersensitivity—Isotretinoin—peripheral nervous system neoplasm	0.000236	0.00144	CcSEcCtD
Ticagrelor—Skin disorder—Alitretinoin—peripheral nervous system neoplasm	0.000236	0.00144	CcSEcCtD
Ticagrelor—Renal failure acute—Epirubicin—peripheral nervous system neoplasm	0.000234	0.00143	CcSEcCtD
Ticagrelor—Hypersensitivity—Melphalan—peripheral nervous system neoplasm	0.000233	0.00142	CcSEcCtD
Ticagrelor—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000232	0.00141	CcSEcCtD
Ticagrelor—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.00023	0.0014	CcSEcCtD
Ticagrelor—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.00023	0.0014	CcSEcCtD
Ticagrelor—Nervous system disorder—Vincristine—peripheral nervous system neoplasm	0.000229	0.0014	CcSEcCtD
Ticagrelor—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000228	0.00139	CcSEcCtD
Ticagrelor—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Ticagrelor—Hypotension—Alitretinoin—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Ticagrelor—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Ticagrelor—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000227	0.00138	CcSEcCtD
Ticagrelor—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000226	0.00138	CcSEcCtD
Ticagrelor—Back pain—Etoposide—peripheral nervous system neoplasm	0.000225	0.00137	CcSEcCtD
Ticagrelor—Pruritus—Melphalan—peripheral nervous system neoplasm	0.000224	0.00137	CcSEcCtD
Ticagrelor—Cardiac failure—Epirubicin—peripheral nervous system neoplasm	0.000221	0.00135	CcSEcCtD
Ticagrelor—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.000221	0.00135	CcSEcCtD
Ticagrelor—Cardiac failure congestive—Doxorubicin—peripheral nervous system neoplasm	0.00022	0.00135	CcSEcCtD
Ticagrelor—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000219	0.00134	CcSEcCtD
Ticagrelor—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000219	0.00134	CcSEcCtD
Ticagrelor—Hypotension—Vincristine—peripheral nervous system neoplasm	0.000219	0.00133	CcSEcCtD
Ticagrelor—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000218	0.00133	CcSEcCtD
Ticagrelor—Renal failure acute—Doxorubicin—peripheral nervous system neoplasm	0.000217	0.00132	CcSEcCtD
Ticagrelor—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000216	0.00132	CcSEcCtD
Ticagrelor—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000216	0.00132	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000216	0.00132	CcSEcCtD
Ticagrelor—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000216	0.00132	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Cisplatin—peripheral nervous system neoplasm	0.000214	0.00131	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000214	0.00131	CcSEcCtD
Ticagrelor—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000214	0.0013	CcSEcCtD
Ticagrelor—Dizziness—Topotecan—peripheral nervous system neoplasm	0.000213	0.0013	CcSEcCtD
Ticagrelor—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000212	0.00129	CcSEcCtD
Ticagrelor—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000212	0.00129	CcSEcCtD
Ticagrelor—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.00021	0.00128	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.00021	0.00128	CcSEcCtD
Ticagrelor—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000209	0.00128	CcSEcCtD
Ticagrelor—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000209	0.00127	CcSEcCtD
Ticagrelor—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000208	0.00127	CcSEcCtD
Ticagrelor—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.00126	CcSEcCtD
Ticagrelor—Body temperature increased—Dactinomycin—peripheral nervous system neoplasm	0.000207	0.00126	CcSEcCtD
Ticagrelor—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000205	0.00125	CcSEcCtD
Ticagrelor—Cardiac failure—Doxorubicin—peripheral nervous system neoplasm	0.000205	0.00125	CcSEcCtD
Ticagrelor—Loss of consciousness—Etoposide—peripheral nervous system neoplasm	0.000204	0.00125	CcSEcCtD
Ticagrelor—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000204	0.00124	CcSEcCtD
Ticagrelor—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000204	0.00124	CcSEcCtD
Ticagrelor—Rash—Topotecan—peripheral nervous system neoplasm	0.000204	0.00124	CcSEcCtD
Ticagrelor—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000203	0.00124	CcSEcCtD
Ticagrelor—Nervous system disorder—Cisplatin—peripheral nervous system neoplasm	0.000203	0.00124	CcSEcCtD
Ticagrelor—Cough—Etoposide—peripheral nervous system neoplasm	0.000203	0.00124	CcSEcCtD
Ticagrelor—Blood creatinine increased—Epirubicin—peripheral nervous system neoplasm	0.000202	0.00124	CcSEcCtD
Ticagrelor—Headache—Topotecan—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Rash—Tretinoin—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000202	0.00123	CcSEcCtD
Ticagrelor—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000201	0.00123	CcSEcCtD
Ticagrelor—Skin disorder—Cisplatin—peripheral nervous system neoplasm	0.000201	0.00123	CcSEcCtD
Ticagrelor—Headache—Isotretinoin—peripheral nervous system neoplasm	0.000201	0.00122	CcSEcCtD
Ticagrelor—Headache—Tretinoin—peripheral nervous system neoplasm	0.000201	0.00122	CcSEcCtD
Ticagrelor—Hypertension—Etoposide—peripheral nervous system neoplasm	0.0002	0.00122	CcSEcCtD
Ticagrelor—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.0002	0.00122	CcSEcCtD
Ticagrelor—Constipation—Vincristine—peripheral nervous system neoplasm	0.0002	0.00122	CcSEcCtD
Ticagrelor—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.0002	0.00122	CcSEcCtD
Ticagrelor—Rash—Melphalan—peripheral nervous system neoplasm	0.000199	0.00122	CcSEcCtD
Ticagrelor—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000199	0.00122	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000198	0.00121	CcSEcCtD
Ticagrelor—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000198	0.00121	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Etoposide—peripheral nervous system neoplasm	0.000196	0.0012	CcSEcCtD
Ticagrelor—Breast disorder—Epirubicin—peripheral nervous system neoplasm	0.000195	0.00119	CcSEcCtD
Ticagrelor—Hypotension—Cisplatin—peripheral nervous system neoplasm	0.000193	0.00118	CcSEcCtD
Ticagrelor—Hypersensitivity—Dactinomycin—peripheral nervous system neoplasm	0.000193	0.00118	CcSEcCtD
Ticagrelor—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00117	CcSEcCtD
Ticagrelor—Body temperature increased—Alitretinoin—peripheral nervous system neoplasm	0.000192	0.00117	CcSEcCtD
Ticagrelor—Nausea—Topotecan—peripheral nervous system neoplasm	0.000192	0.00117	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000191	0.00117	CcSEcCtD
Ticagrelor—Gastritis—Epirubicin—peripheral nervous system neoplasm	0.000191	0.00117	CcSEcCtD
Ticagrelor—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000191	0.00117	CcSEcCtD
Ticagrelor—Nausea—Tretinoin—peripheral nervous system neoplasm	0.00019	0.00116	CcSEcCtD
Ticagrelor—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.00019	0.00116	CcSEcCtD
Ticagrelor—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000188	0.00115	CcSEcCtD
Ticagrelor—Nausea—Melphalan—peripheral nervous system neoplasm	0.000188	0.00115	CcSEcCtD
Ticagrelor—Blood creatinine increased—Doxorubicin—peripheral nervous system neoplasm	0.000187	0.00114	CcSEcCtD
Ticagrelor—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000186	0.00113	CcSEcCtD
Ticagrelor—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000185	0.00113	CcSEcCtD
Ticagrelor—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000185	0.00113	CcSEcCtD
Ticagrelor—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000184	0.00113	CcSEcCtD
Ticagrelor—Skin disorder—Etoposide—peripheral nervous system neoplasm	0.000184	0.00112	CcSEcCtD
Ticagrelor—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000181	0.0011	CcSEcCtD
Ticagrelor—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000179	0.00109	CcSEcCtD
Ticagrelor—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000179	0.00109	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000179	0.00109	CcSEcCtD
Ticagrelor—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000177	0.00108	CcSEcCtD
Ticagrelor—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000177	0.00108	CcSEcCtD
Ticagrelor—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000174	0.00106	CcSEcCtD
Ticagrelor—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000172	0.00105	CcSEcCtD
Ticagrelor—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000172	0.00105	CcSEcCtD
Ticagrelor—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.00017	0.00104	CcSEcCtD
Ticagrelor—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00017	0.00104	CcSEcCtD
Ticagrelor—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000169	0.00103	CcSEcCtD
Ticagrelor—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000168	0.00102	CcSEcCtD
Ticagrelor—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000166	0.00102	CcSEcCtD
Ticagrelor—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000166	0.00101	CcSEcCtD
Ticagrelor—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000165	0.00101	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000164	0.000999	CcSEcCtD
Ticagrelor—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000163	0.000998	CcSEcCtD
Ticagrelor—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000163	0.000997	CcSEcCtD
Ticagrelor—Constipation—Etoposide—peripheral nervous system neoplasm	0.000162	0.000989	CcSEcCtD
Ticagrelor—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.00016	0.00098	CcSEcCtD
Ticagrelor—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00016	0.000977	CcSEcCtD
Ticagrelor—Haematuria—Epirubicin—peripheral nervous system neoplasm	0.000159	0.000969	CcSEcCtD
Ticagrelor—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000157	0.000959	CcSEcCtD
Ticagrelor—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000156	0.000953	CcSEcCtD
Ticagrelor—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000155	0.000949	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.000155	0.000946	CcSEcCtD
Ticagrelor—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000155	0.000944	CcSEcCtD
Ticagrelor—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000154	0.000942	CcSEcCtD
Ticagrelor—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000934	CcSEcCtD
Ticagrelor—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000153	0.000933	CcSEcCtD
Ticagrelor—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000152	0.00093	CcSEcCtD
Ticagrelor—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000152	0.000929	CcSEcCtD
Ticagrelor—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000152	0.000928	CcSEcCtD
Ticagrelor—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.00015	0.000917	CcSEcCtD
Ticagrelor—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.00015	0.000914	CcSEcCtD
Ticagrelor—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00015	0.000914	CcSEcCtD
Ticagrelor—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000149	0.000913	CcSEcCtD
Ticagrelor—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000149	0.000908	CcSEcCtD
Ticagrelor—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000148	0.000906	CcSEcCtD
Ticagrelor—Urinary tract disorder—Epirubicin—peripheral nervous system neoplasm	0.000148	0.000901	CcSEcCtD
Ticagrelor—Rash—Vincristine—peripheral nervous system neoplasm	0.000147	0.0009	CcSEcCtD
Ticagrelor—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000147	0.000899	CcSEcCtD
Ticagrelor—Oedema peripheral—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000899	CcSEcCtD
Ticagrelor—Haematuria—Doxorubicin—peripheral nervous system neoplasm	0.000147	0.000897	CcSEcCtD
Ticagrelor—Connective tissue disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000897	CcSEcCtD
Ticagrelor—Urethral disorder—Epirubicin—peripheral nervous system neoplasm	0.000147	0.000895	CcSEcCtD
Ticagrelor—Headache—Vincristine—peripheral nervous system neoplasm	0.000146	0.000894	CcSEcCtD
Ticagrelor—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000145	0.000887	CcSEcCtD
Ticagrelor—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000144	0.00088	CcSEcCtD
Ticagrelor—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000141	0.000864	CcSEcCtD
Ticagrelor—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000141	0.00086	CcSEcCtD
Ticagrelor—Eye disorder—Epirubicin—peripheral nervous system neoplasm	0.00014	0.000853	CcSEcCtD
Ticagrelor—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	0.00014	0.000852	CcSEcCtD
Ticagrelor—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000139	0.000849	CcSEcCtD
Ticagrelor—Nausea—Vincristine—peripheral nervous system neoplasm	0.000139	0.000848	CcSEcCtD
Ticagrelor—Cardiac disorder—Epirubicin—peripheral nervous system neoplasm	0.000139	0.000847	CcSEcCtD
Ticagrelor—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000138	0.000844	CcSEcCtD
Ticagrelor—Urinary tract disorder—Doxorubicin—peripheral nervous system neoplasm	0.000137	0.000834	CcSEcCtD
Ticagrelor—Oedema peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000832	CcSEcCtD
Ticagrelor—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000136	0.00083	CcSEcCtD
Ticagrelor—Connective tissue disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.00083	CcSEcCtD
Ticagrelor—Angiopathy—Epirubicin—peripheral nervous system neoplasm	0.000136	0.000828	CcSEcCtD
Ticagrelor—Urethral disorder—Doxorubicin—peripheral nervous system neoplasm	0.000136	0.000828	CcSEcCtD
Ticagrelor—Immune system disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000824	CcSEcCtD
Ticagrelor—Mediastinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000135	0.000822	CcSEcCtD
Ticagrelor—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000134	0.000818	CcSEcCtD
Ticagrelor—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000131	0.000803	CcSEcCtD
Ticagrelor—Mental disorder—Epirubicin—peripheral nervous system neoplasm	0.000131	0.0008	CcSEcCtD
Ticagrelor—Rash—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000796	CcSEcCtD
Ticagrelor—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000795	CcSEcCtD
Ticagrelor—Malnutrition—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000794	CcSEcCtD
Ticagrelor—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00013	0.000791	CcSEcCtD
Ticagrelor—Eye disorder—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.000789	CcSEcCtD
Ticagrelor—Cardiac disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000784	CcSEcCtD
Ticagrelor—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000126	0.000768	CcSEcCtD
Ticagrelor—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000766	CcSEcCtD
Ticagrelor—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000125	0.000765	CcSEcCtD
Ticagrelor—Immune system disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000763	CcSEcCtD
Ticagrelor—Mediastinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000761	CcSEcCtD
Ticagrelor—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000123	0.00075	CcSEcCtD
Ticagrelor—Mental disorder—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.00074	CcSEcCtD
Ticagrelor—Vomiting—Etoposide—peripheral nervous system neoplasm	0.00012	0.000735	CcSEcCtD
Ticagrelor—Malnutrition—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000735	CcSEcCtD
Ticagrelor—Rash—Etoposide—peripheral nervous system neoplasm	0.000119	0.000729	CcSEcCtD
Ticagrelor—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.000119	0.000729	CcSEcCtD
Ticagrelor—Headache—Etoposide—peripheral nervous system neoplasm	0.000119	0.000725	CcSEcCtD
Ticagrelor—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000714	CcSEcCtD
Ticagrelor—Syncope—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000712	CcSEcCtD
Ticagrelor—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000116	0.000711	CcSEcCtD
Ticagrelor—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000698	CcSEcCtD
Ticagrelor—Cough—Epirubicin—peripheral nervous system neoplasm	0.000114	0.000693	CcSEcCtD
Ticagrelor—Nausea—Etoposide—peripheral nervous system neoplasm	0.000113	0.000687	CcSEcCtD
Ticagrelor—Hypertension—Epirubicin—peripheral nervous system neoplasm	0.000112	0.000686	CcSEcCtD
Ticagrelor—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000676	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000672	CcSEcCtD
Ticagrelor—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.00066	CcSEcCtD
Ticagrelor—Syncope—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000659	CcSEcCtD
Ticagrelor—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000107	0.000654	CcSEcCtD
Ticagrelor—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000646	CcSEcCtD
Ticagrelor—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000105	0.000641	CcSEcCtD
Ticagrelor—Shock—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000638	CcSEcCtD
Ticagrelor—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	0.000104	0.000636	CcSEcCtD
Ticagrelor—Hypertension—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000635	CcSEcCtD
Ticagrelor—Skin disorder—Epirubicin—peripheral nervous system neoplasm	0.000103	0.00063	CcSEcCtD
Ticagrelor—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000626	CcSEcCtD
Ticagrelor—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000621	CcSEcCtD
Ticagrelor—Hypotension—Epirubicin—peripheral nervous system neoplasm	9.92e-05	0.000606	CcSEcCtD
Ticagrelor—Confusional state—Doxorubicin—peripheral nervous system neoplasm	9.91e-05	0.000605	CcSEcCtD
Ticagrelor—Shock—Doxorubicin—peripheral nervous system neoplasm	9.67e-05	0.00059	CcSEcCtD
Ticagrelor—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	9.64e-05	0.000588	CcSEcCtD
Ticagrelor—Skin disorder—Doxorubicin—peripheral nervous system neoplasm	9.54e-05	0.000583	CcSEcCtD
Ticagrelor—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	9.53e-05	0.000582	CcSEcCtD
Ticagrelor—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	9.47e-05	0.000578	CcSEcCtD
Ticagrelor—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	9.35e-05	0.000571	CcSEcCtD
Ticagrelor—Hypotension—Doxorubicin—peripheral nervous system neoplasm	9.18e-05	0.000561	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	9.17e-05	0.00056	CcSEcCtD
Ticagrelor—Fatigue—Epirubicin—peripheral nervous system neoplasm	9.15e-05	0.000559	CcSEcCtD
Ticagrelor—Constipation—Epirubicin—peripheral nervous system neoplasm	9.08e-05	0.000554	CcSEcCtD
Ticagrelor—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	8.82e-05	0.000539	CcSEcCtD
Ticagrelor—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	8.76e-05	0.000535	CcSEcCtD
Ticagrelor—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	8.75e-05	0.000534	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.00053	CcSEcCtD
Ticagrelor—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000528	CcSEcCtD
Ticagrelor—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	8.48e-05	0.000518	CcSEcCtD
Ticagrelor—Fatigue—Doxorubicin—peripheral nervous system neoplasm	8.47e-05	0.000517	CcSEcCtD
Ticagrelor—Constipation—Doxorubicin—peripheral nervous system neoplasm	8.4e-05	0.000513	CcSEcCtD
Ticagrelor—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000513	CcSEcCtD
Ticagrelor—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	8.39e-05	0.000513	CcSEcCtD
Ticagrelor—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	8.1e-05	0.000494	CcSEcCtD
Ticagrelor—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000491	CcSEcCtD
Ticagrelor—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	7.82e-05	0.000478	CcSEcCtD
Ticagrelor—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000474	CcSEcCtD
Ticagrelor—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	7.77e-05	0.000474	CcSEcCtD
Ticagrelor—Asthenia—Epirubicin—peripheral nervous system neoplasm	7.62e-05	0.000465	CcSEcCtD
Ticagrelor—Pruritus—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000459	CcSEcCtD
Ticagrelor—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	7.27e-05	0.000444	CcSEcCtD
Ticagrelor—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	7.24e-05	0.000442	CcSEcCtD
Ticagrelor—Asthenia—Doxorubicin—peripheral nervous system neoplasm	7.05e-05	0.00043	CcSEcCtD
Ticagrelor—Dizziness—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.000429	CcSEcCtD
Ticagrelor—Pruritus—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000424	CcSEcCtD
Ticagrelor—Vomiting—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000412	CcSEcCtD
Ticagrelor—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.00041	CcSEcCtD
Ticagrelor—Rash—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000409	CcSEcCtD
Ticagrelor—Dermatitis—Epirubicin—peripheral nervous system neoplasm	6.69e-05	0.000408	CcSEcCtD
Ticagrelor—Headache—Epirubicin—peripheral nervous system neoplasm	6.65e-05	0.000406	CcSEcCtD
Ticagrelor—Dizziness—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000397	CcSEcCtD
Ticagrelor—Nausea—Epirubicin—peripheral nervous system neoplasm	6.31e-05	0.000385	CcSEcCtD
Ticagrelor—Vomiting—Doxorubicin—peripheral nervous system neoplasm	6.25e-05	0.000381	CcSEcCtD
Ticagrelor—Rash—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000378	CcSEcCtD
Ticagrelor—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	6.19e-05	0.000378	CcSEcCtD
Ticagrelor—Headache—Doxorubicin—peripheral nervous system neoplasm	6.16e-05	0.000376	CcSEcCtD
Ticagrelor—Nausea—Doxorubicin—peripheral nervous system neoplasm	5.84e-05	0.000356	CcSEcCtD
